Kane Biotech Inc. (TSXV:KNE)
0.0300
0.00 (0.00%)
Jun 10, 2026, 3:44 PM EST
Kane Biotech Revenue
Kane Biotech had revenue of 43.22K CAD in the quarter ending March 31, 2026, a decrease of -89.52%. This brings the company's revenue in the last twelve months to 58.57K, down -97.60% year-over-year. In the year 2025, Kane Biotech had annual revenue of 427.87K, down -79.44%.
Revenue (ttm)
58.57K
Revenue Growth
-97.60%
P/S Ratio
105.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 427.87K | -1.65M | -79.44% |
| Dec 31, 2024 | 2.08M | 1.93M | 1,296.75% |
| Dec 31, 2023 | 148.98K | -2.52M | -94.42% |
| Dec 31, 2022 | 2.67M | 1.06M | 65.96% |
| Dec 31, 2021 | 1.61M | 266.21K | 19.84% |
| Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
| Dec 31, 2019 | 1.69M | 1.19M | 234.51% |
| Dec 31, 2018 | 506.27K | 85.80K | 20.41% |
| Dec 31, 2017 | 420.47K | 298.90K | 245.87% |
| Dec 31, 2015 | 121.57K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 159.95K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKane Biotech News
- 12 days ago - Kane Biotech Announces Grant of Stock Options - GlobeNewsWire
- 13 days ago - Kane Biotech Announces First Quarter 2026 Financial Results - GlobeNewsWire
- 13 days ago - Kane Biotech Registration statement: Q1 2026 - Filings
- 13 days ago - Kane Biotech Registration statement: Q1 2026 - Filings
- 13 days ago - Kane Biotech Earnings release: Q1 2026 - Filings
- 13 days ago - Kane Biotech Slides: Investor presentation - Filings
- 15 days ago - Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering - GlobeNewsWire
- 4 weeks ago - Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress - GlobeNewsWire